We have recently identified PTP1B as a critical mediator in the interleukin 13 (IL-13)/IL-13 receptor α2 (IL13Rα2) pathway involved in colorectal cancer (CRC), ovarian cancer and glioblastoma (GBM) progression [7]. Here, IL13 is linked to ovarian carcinoma.